Arisan Therapeutics, Inc. SBIR Phase II Award, September 2021
A SBIR Phase II contract was awarded to Arisan Therapeutics in September, 2021 for $269,361.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense.
Currently, there are no issues on this topic.
Find more entities like Arisan Therapeutics, Inc. SBIR Phase II Award, September 2021
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.